Sector Gamma As as of March 31, 2026
Portfolio Holdings for Sector Gamma As
Sector Gamma As holds 42 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bristol Myers Squibb (BMY) | 11.9 | $50M | 828k | 60.65 | |
| Merck & Co (MRK) | 7.4 | $31M | 260k | 120.29 | |
| Pfizer (PFE) | 7.2 | $31M | 1.1M | 28.08 | |
| Medtronic SHS (MDT) | 5.7 | $24M | 281k | 86.65 | |
| Incyte Corporation (INCY) | 4.5 | $19M | 201k | 94.12 | |
| Amgen (AMGN) | 3.9 | $17M | 47k | 351.85 | |
| Biogen Idec (BIIB) | 3.9 | $17M | 90k | 183.33 | |
| Zimmer Holdings (ZBH) | 3.3 | $14M | 156k | 90.42 | |
| BioMarin Pharmaceutical (BMRN) | 3.2 | $14M | 240k | 56.49 | |
| Becton, Dickinson and (BDX) | 3.1 | $13M | 83k | 157.23 | |
| Anthem (ELV) | 3.0 | $13M | 44k | 292.75 | |
| Ionis Pharmaceuticals (IONS) | 3.0 | $13M | 170k | 75.09 | |
| Cardinal Health (CAH) | 2.7 | $12M | 55k | 211.31 | |
| UnitedHealth (UNH) | 2.3 | $9.9M | 36k | 270.59 | |
| CVS Caremark Corporation (CVS) | 2.3 | $9.7M | 135k | 71.82 | |
| Bruker Corporation (BRKR) | 2.2 | $9.2M | 254k | 36.12 | |
| Ge Healthcare Technologies I Common Stock (GEHC) | 2.1 | $9.0M | 126k | 71.18 | |
| Abbott Laboratories (ABT) | 2.1 | $9.0M | 88k | 102.67 | |
| Gilead Sciences (GILD) | 1.8 | $7.4M | 53k | 139.37 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 1.7 | $7.1M | 93k | 75.85 | |
| Iqvia Holdings (IQV) | 1.6 | $6.9M | 40k | 170.54 | |
| Syndax Pharmaceuticals (SNDX) | 1.6 | $6.7M | 286k | 23.36 | |
| Bio Rad Labs Cl A (BIO) | 1.6 | $6.6M | 24k | 278.75 | |
| Qiagen Nv Ord Shares (QGEN) | 1.5 | $6.5M | 162k | 40.04 | |
| Avantor (AVTR) | 1.3 | $5.5M | 695k | 7.84 | |
| Centene Corporation (CNC) | 1.3 | $5.3M | 162k | 32.74 | |
| Tandem Diabetes Care Com New (TNDM) | 1.2 | $5.1M | 267k | 19.17 | |
| Ptc Therapeutics I (PTCT) | 1.2 | $5.1M | 75k | 68.13 | |
| Labcorp Holdings Com Shs (LH) | 1.2 | $5.1M | 19k | 266.81 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 1.2 | $4.9M | 21k | 228.73 | |
| Edwards Lifesciences (EW) | 1.1 | $4.8M | 60k | 80.08 | |
| Dex (DXCM) | 0.8 | $3.5M | 56k | 62.80 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.8 | $3.4M | 94k | 36.32 | |
| Kura Oncology (KURA) | 0.8 | $3.3M | 412k | 8.13 | |
| Humana (HUM) | 0.8 | $3.3M | 19k | 173.39 | |
| Bridgebio Pharma (BBIO) | 0.8 | $3.3M | 44k | 74.26 | |
| Iovance Biotherapeutics (IOVA) | 0.7 | $3.2M | 900k | 3.51 | |
| Denali Therapeutics (DNLI) | 0.7 | $3.1M | 163k | 19.20 | |
| Ardelyx (ARDX) | 0.7 | $3.1M | 516k | 5.99 | |
| Cogent Biosciences (COGT) | 0.7 | $3.1M | 80k | 38.49 | |
| Organon & Co Common Stock (OGN) | 0.5 | $2.3M | 376k | 5.99 | |
| Arrowhead Pharmaceuticals (ARWR) | 0.4 | $1.9M | 30k | 62.70 |
